[HTML][HTML] The role of statins in vascular disease
PE Laws, JI Spark, PA Cowled, RA Fitridge - European journal of vascular …, 2004 - Elsevier
Background. Recent publications have highlighted the benefits of statins in non-cardiac
occlusive disease but also the failure of vascular surgeons to recognise and treat the risk …
occlusive disease but also the failure of vascular surgeons to recognise and treat the risk …
[HTML][HTML] Editor's choice–pharmaceutical management of small abdominal aortic aneurysms: a systematic review of the clinical evidence
VBC Kokje, JF Hamming, JHN Lindeman - European Journal of Vascular …, 2015 - Elsevier
Background Management of abdominal aortic aneurysms (AAAs) relies on surgical repair of
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …
Pharmacological therapy of abdominal aortic aneurysm: an update
Y Wang, Z Liu, J Ren, M Xiang - Current vascular …, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …
[HTML][HTML] HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms
WRW Wilson, J Evans, PRF Bell… - European journal of …, 2005 - Elsevier
BACKGROUND: An imbalance in matrix metalloproteinases (MMPs) and their inhibitors
(TIMPs) are implicated in AAA formation. 3-Hydroxy-3-methylglutaryl coenzyme-A reductase …
(TIMPs) are implicated in AAA formation. 3-Hydroxy-3-methylglutaryl coenzyme-A reductase …